USE OF PEPTIDES IN TRACING DISEASE AND DEVELOPING VACCINES
摘要
<p>This process invention involves using small peptide fragments (9-50 amino acids in length) in a delayed-type hypersensitivity (DTH) assay to determine, in vivo in humans, the T-lymphocyte epitopes of a large antigen.</p>
